ENHANCING ACMSD ACTIVITY AS A NOVEL GENE THERAPY FOR ALS

$680,458FY2025Defense Health AgencyDOD

Dignity Health, San Francisco CA

Investigators

View source on USAspending →

ENHANCING ACMSD ACTIVITY AS A NOVEL GENE THERAPY FOR ALS · GrantIndex